We are live on
!
Find out more
CS
Credit Suisse Portfolio holdings
AUM
$104B
1-Year Est. Return
34.76%
This Fund
S&P 500
This Quarter
Est. Return
+26.38%
1 Year Est. Return
+34.76%
3 Year Est. Return
+49.35%
5 Year Est. Return
+181.01%
10 Year Est. Return
+398.7%
AUM
$140B
AUM Growth
+$23.9B
(+21%)
Cap. Flow
-$1.4B
Cap. Flow
% of AUM
-1%
Top 10 Holdings %
Top 10 Hldgs %
16.71%
Holding
4,310
New
356
Increased
1,988
Reduced
1,282
Closed
383
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$1.02B |
| 2 |
Amazon
AMZN
|
+$922M |
| 3 |
Apple
AAPL
|
+$920M |
| 4 |
Otis Worldwide
OTIS
|
+$525M |
| 5 |
Trip.com Group
TCOM
|
+$523M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGN
Allergan plc
AGN
|
+$1.9B |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$942M |
| 3 |
Linde
LIN
|
+$582M |
| 4 |
TVIX
VelocityShares Daily 2x VIX Short Term ETN
TVIX
|
+$392M |
| 5 |
McKesson
MCK
|
+$322M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 17.27% |
| 2 | Healthcare | 11.06% |
| 3 | Consumer Discretionary | 9.06% |
| 4 | Financials | 8.78% |
| 5 | Communication Services | 7.41% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2901
James River Group Holdings
JRVR
$220M
| $877K | ﹤0.01% |
19,486
+1,798
| +10% | +$66.8K |
|
|
GNMK
2902
DELISTED
GenMark Diagnostics, Inc
GNMK
| $868K | ﹤0.01% |
59,011
+31,464
| +114% | +$320K |
|
|
CVGW
2903
DELISTED
Calavo Growers
CVGW
| $867K | ﹤0.01% |
13,773
+921
| +7% | +$55.2K |
|
2904
ProShares UltraPro S&P 500
UPRO
$5.63B
| $862K | ﹤0.01% |
38,860
-14,986
| -28% | -$291K |
|
2905
Ingles Markets
IMKTA
$1.69B
| $858K | ﹤0.01% |
19,913
+5,772
| +41% | +$234K |
|
2906
Ardelyx
ARDX
$1.22B
| $857K | ﹤0.01% |
+123,816
| New | +$861K |
|
2907
Safety Insurance
SAFT
$1.52B
| $853K | ﹤0.01% |
11,192
+1,118
| +11% | +$87.6K |
|
|
2908
PUT
Linde
LIN
$229B
| $848K | ﹤0.01% |
4,000
-31,000
| -89% | -$5.99M |
|
2909
Pilgrim's Pride
PPC
$6.35B
| $848K | ﹤0.01% |
50,131
+2,299
| +5% | +$44.8K |
|
2910
Heartland Express
HTLD
$972M
| $847K | ﹤0.01% |
40,664
+14,459
| +55% | +$290K |
|
2911
Pitney Bowes
PBI
$2.5B
| $847K | ﹤0.01% |
326,101
-58,819
| -15% | -$147K |
|
|
CXO
2912
PUT
DELISTED
CONCHO RESOURCES INC.
CXO
| $845K | ﹤0.01% |
16,400
-50,000
| -75% | -$2.76M |
|
2913
Prudential
PUK
$34.7B
| $842K | ﹤0.01% |
28,559
-9,295
| -25% | -$246K |
|
2914
Axcelis
ACLS
$4.06B
| $840K | ﹤0.01% |
30,159
-54,611
| -64% | -$1.33M |
|
2915
iShares US Regional Banks ETF
IAT
$691M
| $840K | ﹤0.01% |
24,851
-65,661
| -73% | -$2.14M |
|
|
MAG
2916
DELISTED
MAG Silver
MAG
| $840K | ﹤0.01% |
59,541
+21,416
| +56% | +$246K |
|
|
SPPI
2917
DELISTED
Spectrum Pharmaceuticals Inc
SPPI
| $840K | ﹤0.01% |
248,639
+175,164
| +238% | +$510K |
|
|
NKLAW
2918
CALL
DELISTED
Nikola Corporation Warrant expiring 6/3/2025
NKLAW
| $840K | ﹤0.01% |
+25,304
| New | +$722K |
|
|
NXRT
2919
NexPoint Residential Trust
NXRT
$633M
| $839K | ﹤0.01% |
23,721
-28,112
| -54% | -$870K |
|
2920
REX American Resources
REX
$1.46B
| $837K | ﹤0.01% |
72,342
+20,430
| +39% | +$203K |
|
2921
Stewart Information Services
STC
$2.1B
| $835K | ﹤0.01% |
25,681
+3
| +0% | +$90 |
|
|
HTZ
2922
DELISTED
Hertz Global Holdings, Inc.
HTZ
| $828K | ﹤0.01% |
587,395
+138,232
| +31% | +$439K |
|
2923
CALL
Roku
ROKU
$22.2B
| $827K | ﹤0.01% |
7,100
-74,900
| -91% | -$8.57M |
|
2924
MYR Group
MYRG
$5.17B
| $826K | ﹤0.01% |
25,893
+7,352
| +40% | +$201K |
|
2925
Rhythm Pharmaceuticals
RYTM
$7.58B
| $826K | ﹤0.01% |
37,053
+22,915
| +162% | +$447K |
|
Similar funds
CSIA
CAN
VAM
CA
MNG
DPAM
ICG
CW
Credit Suisse's Q2 2020 Portfolio in Review
As of Q2 2020, Credit Suisse held 4,310 positions worth $140B, up 21% from $116B the previous quarter. Its ten largest holdings account for 17% of the portfolio.
Credit Suisse's Q2 2020 filing shows 356 new, 1,988 increased, 1,282 reduced and 383 closed positions. Its largest new stake was Otis Worldwide: 10,131,011 shares worth $576M. The largest sale was Allergan plc, an estimated $1.9B.
By sector, the portfolio is most concentrated in Technology at 17% of assets, up from 14% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- Credit Suisse's largest Q2 2020 buy was Otis Worldwide: 10,131,011 shares worth $576M.
- Credit Suisse added most to Microsoft in Q2 2020, an estimated $1.02B increase.
- Credit Suisse's biggest Q2 2020 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $942M.
- Credit Suisse fully exited Allergan plc in Q2 2020, selling an estimated $1.9B.
- Credit Suisse's ten largest holdings make up 17% of its $140B portfolio in Q2 2020.
- Credit Suisse opened 356 new positions and closed 383 in Q2 2020.
- Credit Suisse's portfolio value rose 21% quarter-over-quarter to $140B.
Based on Credit Suisse's 13F filing for Q2 2020, filed 12 Aug 2020.